Tissue renin-angiotensin system in lacrimal gland fibrosis in a murine model of chronic graft-versus-host disease

Saori Yaguchi, Yoko Ogawa, Tetsuya Kawakita, Shigeto Shimmura, Kazuo Tsubota

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Chronic graft-versus-host disease (cGVHD) is a serious complication known to occur after allogeneic hematopoietic stem cell transplantation. Clinical manifestation includes inflammation and fibrosis. Many peripheral tissues are capable of generating the renin-angiotensin system (RAS) components, called the tissue RAS, and have various roles in tissue-specific physiological and pathological functions of inflammation and fibrosis. This article reviews evidence for the presence of the tissue RAS in the normal mouse lacrimal gland, the role of the tissue RAS in the fibrotic pathogenesis of the lacrimal gland in cGVHD model mice, and the effect of angiotensin II receptor blockers on preventing lacrimal gland fibrosis. B10.D2→BALB/c (H-2d) major histocompatibility complex-compatible, minor histocompatibility antigen-mismatched mice were used as a model of cGVHD, which reflects the clinical and pathological symptoms of human cGVHD. We also describe the localization of RAS components in the normal mouse lacrimal gland. In addition, we characterize the inflammatory and fibrotic changes of the lacrimal gland in cGVHD model mice, demonstrate that fibroblasts strongly express angiotensin II, angiotensin II type 1 receptor (AT1R), and angiotensin II type 2 receptor, and show that mRNA expression of angiotensinogen increased in the lacrimal gland of cGVHD model mice. Inhibitory experiments revealed that lacrimal gland fibrosis was suppressed in mice treated with an AT1R blocker, but not in mice treated with an angiotensin II type 2 receptor blocker. Hence, we conclude that the tissue RAS is involved in the fibrotic pathogenesis of the lacrimal gland and that AT1R blockers have a therapeutic effect on lacrimal gland fibrosis in cGVHD model mice.

Original languageEnglish
Pages (from-to)S142-S152
JournalCornea
Volume34
Publication statusPublished - 2015 Oct 9

Fingerprint

Lacrimal Apparatus
Graft vs Host Disease
Renin-Angiotensin System
Fibrosis
Angiotensin II Type 1 Receptor Blockers
Angiotensin II Type 2 Receptor Blockers
Minor Histocompatibility Antigens
Angiotensin Type 2 Receptor
Inflammation
Angiotensinogen
Angiotensin Type 1 Receptor
Angiotensin Receptor Antagonists
Hematopoietic Stem Cell Transplantation
Therapeutic Uses
Major Histocompatibility Complex
Angiotensin II
Fibroblasts
Messenger RNA

Keywords

  • Chronic graft-versus-host disease
  • Fibrosis
  • Lacrimal gland
  • Tissue renin-angiotensin system

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Tissue renin-angiotensin system in lacrimal gland fibrosis in a murine model of chronic graft-versus-host disease. / Yaguchi, Saori; Ogawa, Yoko; Kawakita, Tetsuya; Shimmura, Shigeto; Tsubota, Kazuo.

In: Cornea, Vol. 34, 09.10.2015, p. S142-S152.

Research output: Contribution to journalArticle

@article{00c09e5c81bf431d917d462d5815ca05,
title = "Tissue renin-angiotensin system in lacrimal gland fibrosis in a murine model of chronic graft-versus-host disease",
abstract = "Chronic graft-versus-host disease (cGVHD) is a serious complication known to occur after allogeneic hematopoietic stem cell transplantation. Clinical manifestation includes inflammation and fibrosis. Many peripheral tissues are capable of generating the renin-angiotensin system (RAS) components, called the tissue RAS, and have various roles in tissue-specific physiological and pathological functions of inflammation and fibrosis. This article reviews evidence for the presence of the tissue RAS in the normal mouse lacrimal gland, the role of the tissue RAS in the fibrotic pathogenesis of the lacrimal gland in cGVHD model mice, and the effect of angiotensin II receptor blockers on preventing lacrimal gland fibrosis. B10.D2→BALB/c (H-2d) major histocompatibility complex-compatible, minor histocompatibility antigen-mismatched mice were used as a model of cGVHD, which reflects the clinical and pathological symptoms of human cGVHD. We also describe the localization of RAS components in the normal mouse lacrimal gland. In addition, we characterize the inflammatory and fibrotic changes of the lacrimal gland in cGVHD model mice, demonstrate that fibroblasts strongly express angiotensin II, angiotensin II type 1 receptor (AT1R), and angiotensin II type 2 receptor, and show that mRNA expression of angiotensinogen increased in the lacrimal gland of cGVHD model mice. Inhibitory experiments revealed that lacrimal gland fibrosis was suppressed in mice treated with an AT1R blocker, but not in mice treated with an angiotensin II type 2 receptor blocker. Hence, we conclude that the tissue RAS is involved in the fibrotic pathogenesis of the lacrimal gland and that AT1R blockers have a therapeutic effect on lacrimal gland fibrosis in cGVHD model mice.",
keywords = "Chronic graft-versus-host disease, Fibrosis, Lacrimal gland, Tissue renin-angiotensin system",
author = "Saori Yaguchi and Yoko Ogawa and Tetsuya Kawakita and Shigeto Shimmura and Kazuo Tsubota",
year = "2015",
month = "10",
day = "9",
language = "English",
volume = "34",
pages = "S142--S152",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Tissue renin-angiotensin system in lacrimal gland fibrosis in a murine model of chronic graft-versus-host disease

AU - Yaguchi, Saori

AU - Ogawa, Yoko

AU - Kawakita, Tetsuya

AU - Shimmura, Shigeto

AU - Tsubota, Kazuo

PY - 2015/10/9

Y1 - 2015/10/9

N2 - Chronic graft-versus-host disease (cGVHD) is a serious complication known to occur after allogeneic hematopoietic stem cell transplantation. Clinical manifestation includes inflammation and fibrosis. Many peripheral tissues are capable of generating the renin-angiotensin system (RAS) components, called the tissue RAS, and have various roles in tissue-specific physiological and pathological functions of inflammation and fibrosis. This article reviews evidence for the presence of the tissue RAS in the normal mouse lacrimal gland, the role of the tissue RAS in the fibrotic pathogenesis of the lacrimal gland in cGVHD model mice, and the effect of angiotensin II receptor blockers on preventing lacrimal gland fibrosis. B10.D2→BALB/c (H-2d) major histocompatibility complex-compatible, minor histocompatibility antigen-mismatched mice were used as a model of cGVHD, which reflects the clinical and pathological symptoms of human cGVHD. We also describe the localization of RAS components in the normal mouse lacrimal gland. In addition, we characterize the inflammatory and fibrotic changes of the lacrimal gland in cGVHD model mice, demonstrate that fibroblasts strongly express angiotensin II, angiotensin II type 1 receptor (AT1R), and angiotensin II type 2 receptor, and show that mRNA expression of angiotensinogen increased in the lacrimal gland of cGVHD model mice. Inhibitory experiments revealed that lacrimal gland fibrosis was suppressed in mice treated with an AT1R blocker, but not in mice treated with an angiotensin II type 2 receptor blocker. Hence, we conclude that the tissue RAS is involved in the fibrotic pathogenesis of the lacrimal gland and that AT1R blockers have a therapeutic effect on lacrimal gland fibrosis in cGVHD model mice.

AB - Chronic graft-versus-host disease (cGVHD) is a serious complication known to occur after allogeneic hematopoietic stem cell transplantation. Clinical manifestation includes inflammation and fibrosis. Many peripheral tissues are capable of generating the renin-angiotensin system (RAS) components, called the tissue RAS, and have various roles in tissue-specific physiological and pathological functions of inflammation and fibrosis. This article reviews evidence for the presence of the tissue RAS in the normal mouse lacrimal gland, the role of the tissue RAS in the fibrotic pathogenesis of the lacrimal gland in cGVHD model mice, and the effect of angiotensin II receptor blockers on preventing lacrimal gland fibrosis. B10.D2→BALB/c (H-2d) major histocompatibility complex-compatible, minor histocompatibility antigen-mismatched mice were used as a model of cGVHD, which reflects the clinical and pathological symptoms of human cGVHD. We also describe the localization of RAS components in the normal mouse lacrimal gland. In addition, we characterize the inflammatory and fibrotic changes of the lacrimal gland in cGVHD model mice, demonstrate that fibroblasts strongly express angiotensin II, angiotensin II type 1 receptor (AT1R), and angiotensin II type 2 receptor, and show that mRNA expression of angiotensinogen increased in the lacrimal gland of cGVHD model mice. Inhibitory experiments revealed that lacrimal gland fibrosis was suppressed in mice treated with an AT1R blocker, but not in mice treated with an angiotensin II type 2 receptor blocker. Hence, we conclude that the tissue RAS is involved in the fibrotic pathogenesis of the lacrimal gland and that AT1R blockers have a therapeutic effect on lacrimal gland fibrosis in cGVHD model mice.

KW - Chronic graft-versus-host disease

KW - Fibrosis

KW - Lacrimal gland

KW - Tissue renin-angiotensin system

UR - http://www.scopus.com/inward/record.url?scp=84944060965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944060965&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - S142-S152

JO - Cornea

JF - Cornea

SN - 0277-3740

ER -